|
1
|
Sostegni R, Daperno M, Scaglione N,
Lavagna A, Rocca R and Pera A: Review article: Crohn's disease:
monitoring disease activity. Aliment Pharmacol Ther. 17 Suppl
2:11–17. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Steinhart H: Maintenance therapy in
Crohn's disease. Can J Gastroenterol. 14 Suppl C:23c–28c. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
De Cruz P, Kamm MA, Hamilton AL, Ritchie
KJ, Krejany EO, Gorelik A, Liew D, Prideaux L, Lawrance IC, Andrews
JM, et al: Crohn's disease management after intestinal resection: A
randomised trial. Lancet. 385:1406–1417. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gyger G and Baron M: Systemic sclerosis:
Gastrointestinal disease and its management. Rheum Dis Clin North
Am. 41:459–473. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Park JH, Nam HN, Lee JH, Hong J, Yi DY,
Ryoo E, Jeon IS and Tchah H: Characteristics of upper
gastrointestinal tract involvement in Korean pediatric Crohn's
disease: A multicenter study. Pediatr Gastroenterol Hepatol Nutr.
20:227–235. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Roy A and Lichtiger S: Clostridium
difficile infection: A rarity in patients receiving chronic
antibiotic treatment for Crohn's disease. Inflamm Bowel Dis.
22:648–653. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sofia MA, Lipowska AM, Perez EY, Zmeter N,
Kavitt R and Rubin DT: Poor sleep quality in Crohn's disease is
associated with antibiotic use and Gerd symptom severity.
Gastroenterology. 152:S7992017. View Article : Google Scholar
|
|
8
|
Valizadeh N, Murray AC, Suradkar K,
Al-Mazrou A and Kiran RP: Impact of preoperative steroid or
immunosuppressant use on short-term outcomes following colectomy in
Crohn's disease patients. Tech Coloproctol. 21:217–223. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hazlewood GS, Rezaie A, Borman M,
Panaccione R, Ghosh S, Seow CH, Kuenzig E, Tomlinson G, Siegel CA,
Melmed GY, et al: Comparative effectiveness of immunosuppressants
and biologics for inducing and maintaining remission in Crohn's
disease: A network meta-analysis. Gastroenterology. 148:344–354.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fedorak RN, Feagan BG, Hotte N, Leddin D,
Dieleman LA, Petrunia DM, Enns R, Bitton A, Chiba N, Paré P, et al:
The probiotic VSL#3 has anti-inflammatory effects and could reduce
endoscopic recurrence after surgery for Crohn's disease. Clin
Gastroenterol Hepatol. 13:928–935. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lichtenstein L, Avni-Biron I and
Ben-Bassat O: Probiotics and prebiotics in Crohn's disease
therapies. Best Pract Res Clin Gastroenterol. 30:81–88. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bouguen G, Levesque BG, Feagan BG,
Kavanaugh A, Peyrin-Biroulet L, Colombel JF, Hanauer SB and
Sandborn WJ: Treat to target: A proposed new paradigm for the
management of Crohn's disease. Clin Gastroenterol Hepatol.
13:1042–1050. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Biancone L, Tosti C, Fina D, Fantini M, De
Nigris F, Geremia A and Pallone F: Review article: Maintenance
treatment of Crohn's disease. Aliment Pharmacol Ther. 17 Suppl
2:31–37. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kroeker KI and Lu C: Probiotic Treatment
in Crohn's DiseaseMicrobiota in Gastrointestinal Pathophysiology.
Floch MH, Ringel Y and Walker WA: 1st edition. Academic Press;
Cambridge, MA: pp. 331–341. 2017, View Article : Google Scholar
|
|
15
|
Derwa Y, Gracie DJ, Hamlin PJ and Ford AC:
P622 Efficacy of probiotics in inflammatory bowel disease:
Systematic review and meta-analysis. J Crohn's Colitis. 11 Suppl
1:S398–S399. 2017. View Article : Google Scholar
|
|
16
|
Sands BE: Medical therapy of
steroid-resistant Crohn's disease. Can J Gastroenterol. 14 Suppl
C:33c–37c. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wood P, Henderson P and Wilson D: P516
Adrenal suppression in inflammatory bowel disease patients treated
with glucocorticoids: A systematic review. J Crohn's Colitis. 11
Suppl 1:S342–S343. 2017. View Article : Google Scholar
|
|
18
|
Soriani P, Tontini GE, Neumann H, Ishaq S,
Annunziata ML, Pastorelli L and Vecchi M: Esophageal
post-inflammatory polyposis in extensive and severe Crohn's disease
treated with anti-tumor necrosis factor alpha. Endoscopy. 48 Suppl
1:E261–E262. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang J, Chen SL and Li LB: Correlation
between intestinal flora and serum inflammatory factors in patients
with Crohn's disease. Eur Rev Med Pharmacol Sci. 21:4913–4917.
2017.PubMed/NCBI
|
